Executive Summary Autoimmune Polyglandular Syndrome Type 1 Market Opportunities by Size and Share Data Bridge Market Research analyses that the autoimmune polyglandular syndrome type 1 market was valued at USD 228 million in 2021 and is expected to reach USD 347.26 million by 2029, registering a CAGR of 5.40% during the forecast period of 2022 to 2029. An international Autoimmune Polyglandular...